Fig. 2.
Predictive merit of immune stratification based on TAMs infiltration and M2/M1 ratio with response to cisplatin-based adjuvant chemotherapy in MIBC. A-B Kaplan–Meier curves estimates of OS A and RFS B stratified according to ACT application in ZSHS cohort. C-D Kaplan–Meier curves for OS C and RFS D stratified according to ACT application combined with TAMs infiltration and M2/M1 ratio. Data were analyzed by log-rank test